Category Archives: Healthcare

Healthcare Press Releases & News distributed via EuropaWire

University of Southampton Scientists Engineer Super-Strong Antibody to Boost Immune Response Against Cancer

(IN BRIEF) Scientists at the University of Southampton have engineered a new type of super-strong antibody, which could significantly enhance immune system responses in cancer patients. By altering the shape and rigidity of antibodies, the team discovered that these modified … Read the full press release

New FOxTROT 5 Trial by University of Glasgow, University of Leeds, and University of Birmingham Aims to Transform Colon Cancer Treatment for Elderly Patients with Promising Immunotherapy Approach

(IN BRIEF) The University of Glasgow is leading the innovative FOxTROT 5 trial, which is offering elderly colon cancer patients the opportunity to participate in a groundbreaking immunotherapy study. The trial will administer dostarlimab before surgery, targeting a specific type … Read the full press release

Mentoring Initiative for Minority Women in Medical and Health Sciences Shows Positive Impact on Career Progression and Inclusivity

(IN BRIEF) The AIMMS initiative, a mentorship program designed to support minority women in academic medicine and health sciences, has proven to be an effective tool in breaking down barriers and promoting career advancement. Developed by the University of Southampton … Read the full press release

SGS Belgium NV Receives Designation as Notified Body under EU IVDR to Support In Vitro Diagnostic Device Compliance

(IN BRIEF) SGS Belgium NV has been officially designated by the European Commission and Belgian Competent Authority as a Notified Body (NB) under the In Vitro Diagnostic Medical Device Regulation (IVDR), EU 2017/746. This milestone enhances SGS’s ability to support … Read the full press release

Sidekick Health Secures €35 Million Funding from EIB to Expand Digital Therapeutics and AI Capabilities

(IN BRIEF) Sidekick Health has secured a €35 million venture debt facility from the European Investment Bank (EIB) to advance its digital health and therapeutics initiatives. The funding, backed by the European Commission’s InvestEU initiative, will accelerate R&D and AI-driven … Read the full press release

Sanofi Sells 50% Stake in Opella to CD&R, Establishing Independent Global Consumer Healthcare Champion

(IN BRIEF) Sanofi has completed the sale of a 50.0% controlling stake in its consumer healthcare division, Opella, to CD&R, creating a global leader in consumer healthcare. Sanofi retains a significant 48.2% stake, while Bpifrance will hold 1.8% and join … Read the full press release

Dr. Mumtaz Patel from the University of Liverpool Becomes the 123rd President of the Royal College of Physicians

(IN BRIEF) Dr. Mumtaz Patel has been elected the 123rd president of the Royal College of Physicians (RCP), making her the first woman of Indian descent to hold this esteemed position. Dr. Patel, a consultant nephrologist and educator at the … Read the full press release

New Study Reveals Alarming Rise in Ketamine Addiction, Highlighting Serious Health Risks and Barriers to Treatment

(IN BRIEF) A new study led by the University of Exeter and University College London (UCL) sheds light on the growing issue of ketamine addiction, revealing significant physical and psychological health problems among users, many of whom are unaware of … Read the full press release

Empa Study Finds Urban Green Spaces Crucial for Stress Relief Amid Noise Pollution

(IN BRIEF) A comprehensive study by Empa and the Swiss Federal Institute for Forest, Snow and Landscape Research (WSL), funded by the Swiss National Science Foundation (SNSF), has revealed the significant role of urban green spaces in alleviating stress caused … Read the full press release

Merck to Acquire SpringWorks Therapeutics, Expanding Leadership in Rare Tumors and Advancing Healthcare Innovation

(IN BRIEF) Merck has entered into a definitive agreement to acquire SpringWorks Therapeutics for approximately $3.9 billion. This acquisition will significantly enhance Merck’s rare tumor portfolio, adding first-in-class therapies for desmoid tumors and NF1-PN. The deal aligns with Merck’s strategy … Read the full press release

University of Twente and Labmicta Partner to Revolutionize Laboratory Diagnostics with AI and Robotics

(IN BRIEF) The University of Twente and Labmicta have formed a strategic partnership to advance laboratory diagnostics through the integration of artificial intelligence (AI) and robotics. This collaboration aims to optimize diagnostic processes, reduce turnaround times, and improve patient care … Read the full press release

ZEISS Axioscan 7 Spatial Biology Revolutionizes Clinical Research with Scalable Workflow Automation

(IN BRIEF) ZEISS has launched the Axioscan 7 spatial biology, a high-performance slide scanner designed for clinical research applications in spatial biology. The system supports high-throughput, automated imaging for multiplex immunofluorescence (mIF) assays, providing researchers with faster, more efficient, and … Read the full press release

Sanofi’s Foundation S and Sobi Renew Partnership with WFH Humanitarian Aid Program

(IN BRIEF) Sanofi and Sobi have renewed their partnership with the World Federation of Hemophilia (WFH) to support the WFH Humanitarian Aid Program for up to five years. The new agreement includes the donation of up to 100 million international … Read the full press release

University of Copenhagen Researchers Create ‘Super Stem Cells’ with Enhanced Regenerative Capabilities

(IN BRIEF) Researchers from the University of Copenhagen have created “super stem cells” by altering the cells’ diet, enhancing their ability to differentiate into various cell types such as liver, skin, and nerve cells. This development has significant implications for … Read the full press release

New Study Links Testicular Cancer Risk to Rare Genetic Variants Involved in Cell Structure and Movement

(IN BRIEF) The largest study to date on testicular germ cell tumours (TGCTs) has revealed a potential link between testicular cancer risk and rare genetic variants affecting cellular movement and structure. Conducted by The Institute of Cancer Research, London, the … Read the full press release

Evotec Achieves Major Milestones in Molecular Glue Degrader Collaboration with Bristol Myers Squibb, Unlocks $75 Million in Payments

(IN BRIEF) Evotec SE has reached key milestones in its molecular glue degrader collaboration with Bristol Myers Squibb, earning $75 million in performance- and program-based payments. The partnership, built on Evotec’s AI-driven drug discovery platforms and BMS’s CELMoD™ technology, continues … Read the full press release

Eckert & Ziegler to Supply Clinical-Grade Y90-PentixaTher Doses for Pentixapharm Trials

(IN BRIEF) Eckert & Ziegler Radiopharma GmbH has entered into a clinical manufacturing agreement with Pentixapharm AG to supply GMP-grade Y90-PentixaTher doses for use in ongoing trials. The radiolabeled therapy targets cancers overexpressing the CXCR4 receptor and supports a theranostic … Read the full press release

Basilea Achieves Second Consecutive Sales Milestone for Cresemba in Japan Through Asahi Kasei Pharma Partnership

(IN BRIEF) Basilea Pharmaceutica has received a CHF 1.7 million milestone payment from its partner Asahi Kasei Pharma following continued strong sales of Cresemba® in Japan—marking the second consecutive quarterly milestone. Cresemba, now marketed in over 70 countries, achieved USD … Read the full press release

Southampton Leads £4.5M UK-Wide Research Network Exploring How Gut Health Influences the Brain and Immune System

(IN BRIEF) A new UK research network led by the University of Southampton is investigating how the gut microbiome influences the brain and immune system. With £4.5 million in BBSRC funding, the four-year project brings together scientists from Southampton, Cambridge, … Read the full press release

TUM Breakthrough: Synthetic Peptides Disrupt Protein Aggregation Across Parkinson’s, Alzheimer’s, and Diabetes

(IN BRIEF) A team at the Technical University of Munich has developed synthetic macrocyclic peptides that inhibit harmful protein aggregation linked to Parkinson’s disease. The peptides also block the interactions between proteins involved in Alzheimer’s and type 2 diabetes, which … Read the full press release